XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (41,911) $ (46,078)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,041 3,953
Stock-based compensation expense 33,291 29,108
Amortization of deferred contract acquisition costs 11,621 11,850
Provision for allowance for doubtful accounts and billing reserve 2,360 1,203
Non-cash lease expense 1,339 1,475
Accretion of marketable securities (5,853) (117)
Lease impairment charge 1,461 0
Other 206 103
Changes in operating assets and liabilities:    
Accounts receivable 15,512 13,741
Deferred contract acquisition costs (8,681) (10,040)
Prepaid expenses and other assets (43) (5)
Accounts payable (2,128) 263
Accrued liabilities (3,037) (1,369)
Deferred revenue (16,850) (15,231)
Other liabilities (2,671) (1,749)
Net cash used in operating activities (11,343) (12,893)
Cash flows from investing activities:    
Purchase of property and equipment (1,076) (2,400)
Acquisition, net of cash acquired 0 (2,495)
Purchase of marketable securities (232,504) (211,310)
Proceeds from maturities of marketable securities 319,466 121,965
Proceeds from sale of marketable securities 17,739 0
Net cash provided by (used in) investing activities 103,625 (94,240)
Cash flows from financing activities:    
Proceeds from exercise of stock options 1,341 2,467
Proceeds from issuance of common stock under ESPP 546 833
Payment of tax withholding obligations related to net share settlements on equity awards 0 (1,756)
Payment for repurchase of common stock (59,239) (21,808)
Payment of cash dividend (49,872) 0
Repayment of equipment loans (187) (201)
Repayment of finance lease obligations (1,315) (1,399)
Net cash used in financing activities (108,726) (21,864)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 164 487
Net decrease in cash, cash equivalents and restricted cash (16,280) (128,510)
Cash, cash equivalents and restricted cash, beginning of period 27,169 165,043
Cash, cash equivalents and restricted cash, end of period 10,889 36,533
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets:    
Cash and cash equivalents 10,804 36,367
Restricted cash included in other assets, non-current 85 166
Total cash, cash equivalent, and restricted cash 10,889 36,533
Supplemental disclosures of cash flow information:    
Cash paid for taxes, net of refunds 1,074 353
Cash paid for interest $ 46 $ 120